Abstract
Introduction: Healthcare workers (HCWs) in Saudi Arabia are a unique population who have had exposures to the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It follows that HCWs from this country could have pre-existingMERS-CoV antibodies that may either protect from coronavirus disease 2019 (COVID-19) infection or cause false SARS-CoV-2 seropositive results. In this article, we report the seroprevalence of MERS-CoV and SARS-CoV-2 among high-risk healthcare workers in Riyadh city, Saudi Arabia.
Methods: This is a cross-sectional study enrolling 420 high-risk HCWs who are physically in contact with COVID-19 patients in three tertiary hospitals in Riyadh city. The participants were recruited between the 1st of July to the end of December 2020. A 3 ml of the venous blood samples were collected and tested for the presence of IgG antibodies against the spike proteins of SARS-CoV-2 and MERS-CoV using enzyme-linked immunosorbent assay (ELISA).
Results: The overall prevalence of SARS-CoV-2 in high-risk HCWs was 14.8% based on SARS-CoV-2 IgG testing while only 7.4% were positive by Polymerase Chain Reaction (PCR) for viral RNA. Most of the SARS-CoV-2 seropositive HCWs had symptoms and the most frequent symptoms were body aches, fever, cough, loss of smell and taste, and headache. The seroprevalence of MERS-CoV IgG was 1% (4 participants) and only one participant had dual seropositivity against MERS-CoV and SARS-CoV-2. Three MERS-CoV positive samples (75%) turned to be negative after using in-house ELISA and none of the MERS-CoV seropositive samples had detectable neutralization activity.
Conclusion: Our SARS-CoV-2 seroprevalence results were higher than reported regional seroprevalence studies. This finding was expected and similar to other international findings that targeted high-risk HCWs. Our results provide evidence that the SARS-CoV-2- seropositivity in Saudi Arabia similar to other countries was due to exposure to SARS-CoV-2 rather than MERS-CoV antibody.
Keywords: COVID-19; Healthcare workers; IgG antibody; SARS-CoV-2; Seroprevalence.
【저자키워드】 COVID-19, SARS-CoV-2, Healthcare workers, IgG antibody, seroprevalence., 【초록키워드】 coronavirus disease, IgG, Coronavirus disease 2019, coronavirus, Healthcare workers, antibody, cross-sectional, hospital, Seroprevalence, Infection, severe acute respiratory syndrome coronavirus-2, Symptom, MERS, severe acute respiratory syndrome Coronavirus, cough, headache, MERS-CoV, Saudi Arabia, healthcare worker, ELISA, Prevalence, Severe acute respiratory syndrome, polymerase chain reaction, enzyme-linked immunosorbent assay, cross-sectional study, IgG antibody, Viral, PCR, SARS-CoV-2 seroprevalence, IgG antibodies, HCWs, International, Fever, Patient, Seropositivity, Middle East respiratory syndrome Coronavirus, Viral RNA, Taste, respiratory, seropositive, SARS-CoV-2 IgG, COVID-19 patients, Coronavirus-2, Evidence, Spike proteins, Contact, Middle East, HCW, dual, exposure to, Chain Reaction, contact with, venous blood, Loss of Smell, acute respiratory syndrome, Participants, acute respiratory syndrome coronavirus, reaction, house, in-house ELISA, enzyme, chain, blood sample, loss of smell and taste, participant, neutralization activity, CoV antibodies, respiratory syndrome coronavirus, positive, body aches, MOST, positive sample, country, venous, enzyme-linked immunosorbent, PROTECT, tested, collected, physically, recruited, reported, detectable, unique, the spike protein, expected, seropositive sample, the SARS-CoV-2, with COVID-19, 【제목키워드】 MERS-CoV, healthcare worker, endemic area,